VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Modulating metabolism to increase sensitivity to anti-myeloma drugs & targeting metabolites

Mala Shanmugam, MS, PhD , Emory School of Medicine, Atlanta, GA, comments on modulating metabolism to increase sensitivity to anti-myeloma therapies and discusses the importance of better understanding the role of metabolism in high-risk disease. Dr Shanmugam also highlights the challenges related to targeting metabolites to treat multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter